scholarly article | Q13442814 |
P356 | DOI | 10.1182/BLOOD-2007-07-103200 |
P698 | PubMed publication ID | 18003887 |
P50 | author | Tony J. Kenna | Q37371728 |
Ranjeny Thomas | Q38523203 | ||
Raymond J Steptoe | Q59556035 | ||
P2093 | author name string | R. Thomas | |
R. J. Steptoe | |||
T. J. Kenna | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P1104 | number of pages | 10 | |
P304 | page(s) | 2091-2100 | |
P577 | publication date | 2007-11-14 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses | |
P478 | volume | 111 |
Q42403489 | A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin |
Q48282619 | APC-targeted proinsulin expression inactivates insulin-specific memory CD8+ T cells in NOD mice. |
Q33752348 | Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation |
Q40152307 | Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8+ T-cell priming to tolerance in autoimmune-prone NOD mice |
Q51887160 | Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes. |
Q35151883 | Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment |
Q84015414 | CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor |
Q42176202 | Dendritic cell therapy in composite tissue allotransplantation. |
Q38078552 | Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. |
Q36504414 | Distinct mechanisms mediate naive and memory CD8 T-cell tolerance |
Q37954811 | Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells. |
Q38682156 | Harnessing the properties of dendritic cells in the pursuit of immunological tolerance |
Q50023625 | High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation |
Q37773295 | Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines |
Q45874675 | Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy. |
Q33804736 | Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates |
Q92303151 | Regulatory dendritic cells for human organ transplantation |
Q50177437 | Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies |
Q90413377 | Regulatory dendritic cells: profiling, targeting, and therapeutic application |
Q50993283 | Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells. |
Q34065735 | Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen |
Q42069114 | Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance. |
Q51057483 | Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses. |
Q84185759 | Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection |
Q27337590 | The kinematics of cytotoxic lymphocytes influence their ability to kill target cells |
Q37353045 | Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance |
Q21131223 | Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials |
Q35341379 | Tolerogenic dendritic cells and their role in transplantation. |
Q33811958 | Tolerogenic dendritic cells: all present and correct? |
Q35962433 | γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen |
Search more.